Addex Therapeutics (ADXN) FCF Margin (2019 - 2025)
Addex Therapeutics (ADXN) recorded FCF Margin of -249744.35% in Q4 2025, down 248182.29 percentage points from -1562.07% a year earlier and down 247950.51 percentage points from the prior quarter.
Powered by 
Analysis
Addex Therapeutics (ADXN) FCF Margin (2019 - 2025) Analysis & Trends
For FY2025, Addex Therapeutics reported FCF Margin of -7243.82%, down 5108.15 percentage points from FY2024.
- Annual FCF Margin has a five-year change of -6908.33 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -2135.66% in FY2024 (-1640.57 pp), -495.09% in FY2023 (+660.43 pp), -1155.52% in FY2022 (-652.37 pp) and -503.16% in FY2021 (-167.67 pp).
- The Q4 2025 figure is the lowest quarterly FCF Margin in data going back to Q1 2019.
- On a year-over-year basis, FCF Margin rose in 1 of the last six quarters, with an average year-over-year change of -41345.24 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 9008.90 percentage points in Q3 2021, against a drop of 248182.29 percentage points in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Addex Therapeutics | 4.87 Mn | -4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -249,744.35% |
| Sep 30, 2025 | -1,793.85% |
| Mar 31, 2025 | -1,699.08% |
| Dec 31, 2024 | -1,730.90% |
| Sep 30, 2024 | -740.35% |
| Jun 30, 2024 | -2,391.66% |
| Mar 31, 2024 | -939.86% |
| Dec 31, 2023 | -414.14% |
| Sep 30, 2023 | -683.95% |
| Jun 30, 2023 | -438.32% |
| Mar 31, 2023 | -470.55% |
| Dec 31, 2022 | -518.71% |
| Sep 30, 2022 | -657.01% |
| Jun 30, 2022 | -3,179.79% |
| Mar 31, 2022 | -2,042.10% |
| Dec 31, 2021 | -750.59% |
| Sep 30, 2021 | -370.46% |
| Jun 30, 2021 | -650.92% |
| Mar 31, 2021 | -327.61% |
| Dec 31, 2020 | 34.83% |
API Access
Addex Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();